Cross-reactivity to seasonal coronaviruses may be significant for COVID-19, as studies indicate the presence of SARS-CoV-2 specific CD4 + T cells in individuals not previously exposed.
← all excerpts
Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.
1
—
—